Log In
BCIQ
Print this Print this
 

Abilify Maintena, Once-monthly aripiprazole

Also known as: Aripiprazole depot

  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
DescriptionOnce-monthly intramuscular depot formulation of aripiprazole, a small molecule partial agonist of the dopamine D2 and serotonin (5-HT1A) receptors and antagonist of the serotonin (5-HT2A) receptor
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT) receptor
Mechanism of ActionDopamine D2 receptor agonist; Serotonin (5-HT) receptor agonist/antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$200.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/14/2011

Undisclosed

$200.0M

Undisclosed

Get a free BioCentury trial today